caa a22 4500 397495609 CHVBK 20180308164520.0 cr unu---uuuuu 161202e199502 xx s 000 0 eng 10.1016/S1010-7940(05)80018-1 doi (NATIONALLICENCE)oxford-10.1016/S1010-7940(05)80018-1 Surgical treatment of small cell lung cancer [Elektronische Daten] From 1970 till 1989, 30 patients underwent surgical resection for smallcell lung cancer (SCLC). The 5-year survival in stage I patients was 31%,in stage II 17% and in stage III the projected 5-year survival was 9%.Among N2 patients there were only 25% survivors after 1 year and none after2 years. The first group of 15 patients (1970-1979) received no adjuvantchemotherapy in contrast to the second group of 15 patients (1980-1989).The overall 5-year survival for the first group was 13% and the estimated5-year survival for the second group was 27%. In stage I SCLC, the 5-yearsurvival was 12% and 60%, respectively. These results confirm that surgerymay lead to long-term survival in stage I and possibly stage II SCLC, withbetter prognosis in stage I when adjuvant chemotherapy is added. © Springer-Verlag 1995 European Journal of Cardio-Thoracic Surgery Elsevier Science B.V. 9/2(1995-02), 59-64 1010-7940 9:2<59 1995 9 ejcts https://doi.org/10.1016/S1010-7940(05)80018-1 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1016/S1010-7940(05)80018-1 text/html Onlinezugriff via DOI NATIONALLICENCE 773 0- European Journal of Cardio-Thoracic Surgery Elsevier Science B.V 9/2(1995-02), 59-64 1010-7940 9:2<59 1995 9 ejcts Metadata rights reserved CC BY-NC-4.0 http://creativecommons.org/licenses/by-nc/4.0 nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-oxford